These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system]. Yang Y; Wu WP; Huang DH; Wu L Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372 [TBL] [Abstract][Full Text] [Related]
53. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis. Yanagawa K; Kawachi I; Toyoshima Y; Yokoseki A; Arakawa M; Hasegawa A; Ito T; Kojima N; Koike R; Tanaka K; Kosaka T; Tan CF; Kakita A; Okamoto K; Tsujita M; Sakimura K; Takahashi H; Nishizawa M Neurology; 2009 Nov; 73(20):1628-37. PubMed ID: 19917985 [TBL] [Abstract][Full Text] [Related]
55. [Seroprevalence and diagnostic value of aquaporin-4 antibody in patients with inflammatory central nervous system demyelinating diseases]. Wu L; Yang Y; Huang DH; Wu WP Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):350-2. PubMed ID: 21354891 [TBL] [Abstract][Full Text] [Related]
56. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica. Wegner C Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153 [TBL] [Abstract][Full Text] [Related]
57. Neuromyelitis optica: concept, immunology and treatment. Uzawa A; Mori M; Kuwabara S J Clin Neurosci; 2014 Jan; 21(1):12-21. PubMed ID: 23916471 [TBL] [Abstract][Full Text] [Related]
58. [Recent advances of multiple sclerosis research in Japan]. Kira J Rinsho Shinkeigaku; 2009 Sep; 49(9):549-59. PubMed ID: 19928684 [TBL] [Abstract][Full Text] [Related]
59. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009 [TBL] [Abstract][Full Text] [Related]